Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001808665-25-000009
Filing Date
2025-03-12
Accepted
2025-03-12 17:14:59
Documents
125
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K asrt-20241231.htm   iXBRL 10-K 1947347
2 EX-19.1 exhibit191-fy2024.htm EX-19.1 76291
3 EX-23.1 exhibit231-gtconsent2024.htm EX-23.1 3229
4 EX-31.1 exhibit311-fy2024.htm EX-31.1 11036
5 EX-31.2 exhibit312-fy2024.htm EX-31.2 10854
6 EX-32.1 exhibit321-fy2024.htm EX-32.1 5890
7 EX-32.2 exhibit322-fy2024.htm EX-32.2 5990
  Complete submission text file 0001808665-25-000009.txt   11600935

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT asrt-20241231.xsd EX-101.SCH 79187
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT asrt-20241231_cal.xml EX-101.CAL 130070
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT asrt-20241231_def.xml EX-101.DEF 439491
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT asrt-20241231_lab.xml EX-101.LAB 1002691
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT asrt-20241231_pre.xml EX-101.PRE 737874
128 EXTRACTED XBRL INSTANCE DOCUMENT asrt-20241231_htm.xml XML 1702758
Mailing Address 100 S. SAUNDERS ROAD SUITE 300 LAKE FOREST IL 60045
Business Address 100 S. SAUNDERS ROAD SUITE 300 LAKE FOREST IL 60045 (224) 419-7106
Assertio Holdings, Inc. (Filer) CIK: 0001808665 (see all company filings)

EIN.: 850598378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-39294 | Film No.: 25732720
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)